Viridian Therapeutics, Inc.\DE Annual Return On Assets in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Viridian Therapeutics, Inc.\DE quarterly/annual Return On Assets history and growth rate from 2015 to 2023.
  • Viridian Therapeutics, Inc.\DE Return On Assets for the quarter ending June 30, 2024 was -44.8 %, a 8.62% increase year-over-year.
  • Viridian Therapeutics, Inc.\DE annual Return On Assets for 2023 was -61.1 %, a 44.4% decline from 2022.
  • Viridian Therapeutics, Inc.\DE annual Return On Assets for 2022 was -42.3 %, a 11.4% increase from 2021.
  • Viridian Therapeutics, Inc.\DE annual Return On Assets for 2021 was -47.7 %, a 74.5% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -61.1 -18.8 -44.4% Jan 1, 2023 Dec 31, 2023
2022 -42.3 +5.42 +11.4% Jan 1, 2022 Dec 31, 2022
2021 -47.7 +139 +74.5% Jan 1, 2021 Dec 31, 2021
2020 -187 -90.2 -93.1% Jan 1, 2020 Dec 31, 2020
2019 -96.9 -54.9 -131% Jan 1, 2019 Dec 31, 2019
2018 -42 +9.15 +17.9% Jan 1, 2018 Dec 31, 2018
2017 -51.1 +81.4 +61.4% Jan 1, 2017 Dec 31, 2017
2016 -133 -52.4 -65.4% Jan 1, 2016 Dec 31, 2016
2015 -80.1 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.